Friday, April 5th, 2013 /
Comments Off on Amgen shares top $100 as fears fade over biosimilars
NEXT ARTICLE →Up in the air: When it makes sense to take your small business into the cloud
← PREVIOUS ARTICLEGreen Coast 2013: How the region is leading the way in energy efficiency
View all articles by Stephen Nellis »
You might also like...